REPATHA
AMGEN CANADA INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is REPATHA discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that REPATHA 120MG has been permanently discontinued (last updated July 2, 2025). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is REPATHA not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
REPATHA
AMGEN CANADA INC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02459779
Strength
120MG
Dosage Form
SOLUTION
Route
SUBCUTANEOUS
Compare with another product →
Shortage History
Other Products from AMGEN CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MG · DIN 02459299
50MG · DIN 02459302
50MG · DIN 02459310
40MCG · DIN 02392321
500MCG · DIN 02391791
200MCG · DIN 02391775
25MCG · DIN 02392313
500MCG · DIN 02391821
500MCG · DIN 02391805
100MCG · DIN 02391759
200MCG · DIN 02391783
200MCG · DIN 02391767